LABT 8-K: SEC filing
Filed with the SEC on · accession 0001213900-26-118127
LABT filed a 8-K (current report) with the SEC on Nov 10, 2026. Lakewood-Amedex Biotherapeutics redeemed all 127,097 outstanding shares of its Series C Convertible Preferred Stock from Shakawe Capital LLC for $1,270,970 in cash, equal to the $10.00 per share face value.
Summary of the filing
Lakewood-Amedex Biotherapeutics redeemed all 127,097 outstanding shares of its Series C Convertible Preferred Stock from Shakawe Capital LLC for $1,270,970 in cash, equal to the $10.00 per share face value. The redemption closed on November 4, 2026, and no Series C Preferred Stock remains outstanding.
Key details
✦ Ask GOAX AI about this filing — what it means for LABT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LABT?
Click hereFrequently asked questions
What did LABT file with the SEC on Nov 10, 2026?
LABT filed a 8-K (SEC filing). Lakewood-Amedex Biotherapeutics redeemed all 127,097 outstanding shares of its Series C Convertible Preferred Stock from Shakawe Capital LLC for $1,270,970 in cash, equal to the $10.00 per share face value. The redemption closed on November 4, 2026, and no Series C Preferred Stock remains outstanding.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other LABT SEC filings
Get alerts when LABT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days